Bristol-Myers Squibb Company

Location

New Jersey

Founded

1887-04-10

Risk Signals

10468 news mentions monitored

Industry Context

This company is tracked across risk categories, including those related to its sector (e.g., Pharmaceutical Preparations), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.

Recent Articles about Bristol-Myers Squibb Company

Live alerts from global media, monitored by Business Radar

88th session of the Board of Directors of the BMS-SA: Strengthening actions to combat money laundering and the financing of terrorism in the 2024 outlook

2024-05-22 (bamada.net)

88th session of the Board of Directors of the BMS-SA: Strengthening actions to combat money laundering and the financing of terrorism in the 2024 outlook

The Malian Solidarity Bank (BMS-SA) held the 88th session of its Board of Directors on Tuesday, May 14, 2024, under the chairmanship of Mr. Yéhia Ag Mohamed ALI (Chairman of the Board of Directors).

Read more
88th session of the Board of Directors of the BMS-SA: Strengthening actions to combat money laundering and the financing of terrorism in the 2024 outlook

2024-05-22 (bamada.net)

88th session of the Board of Directors of the BMS-SA: Strengthening actions to combat money laundering and the financing of terrorism in the 2024 outlook

The Malian Solidarity Bank (BMS-SA) held the 88th session of its Board of Directors on Tuesday, May 14, 2024, under the chairmanship of Mr. Yéhia Ag Mohamed ALI (Chairman of the Board of Directors).

Read more
Mayo Clinic, LifePoint Health sue pharmas over 'pay for delay' deals keeping blood cancer drug prices high

2023-10-19 (fiercehealthcare.com)

Mayo Clinic, LifePoint Health sue pharmas over 'pay for delay' deals keeping blood cancer drug prices high

The Mayo Clinic and LifePoint Health believe that collusion within the pharmaceutical industry forced their organizations to overpay for the multiple myeloma drug Revlimid and are petitioning the c | The health systems said agreements between Revlimid's owners, Celgene and Bristol-Myers Squibb, and other drugmakers that delayed full production of generic alternatives are anticompetitive and have forced their organizations to overpay.

Read more
Live news updates: UK says Bulb Energy bailout will push government borrowing up by £1.2bn

2022-04-28 (ft.com)

Live news updates: UK says Bulb Energy bailout will push government borrowing up by £1.2bn

Live news updates: UK says Bulb Energy bailout will push government borrowing up by £1.2bn

Read more

Never miss a headline about Bristol-Myers Squibb Company

Set up smart alerts with Business Radar and receive real-time updates on any new risk signal or major news story.

  • ✔️ Used by 100+ compliance teams and analysts
  • ✔️ Covers 154M+ sources in 40+ languages